HCRT and metabolic dysfunction-associated steatohepatitis: After an intervention with daily supplementation of orexin A, through intracerebroventricular injection, an attenuation of inflammation and hepatic endoplasmic stress was observed, concluding that adequate levels of orexin A could prevent NASH and HCC progression (43).